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Recovery after ECT: comparison of propofol, 
etomidate and thiopental
Recuperação pós-eletroconvulsoterapia: 
comparação entre propofol, etomidato e tiopental
Abstract
Objectives: To compare post anesthetic time for patient recovery after electroconvulsive therapy, as measured by the post anesthetic 
Recovery Score of Aldrete and Kroulik, using three different types of hypnotic drugs (propofol, etomidate and thiopental). Method: Thirty 
patients were randomized to receive one of the three drugs (n = 10 in each group), during a course of electroconvulsive therapy treatment. 
Patients and raters were blinded to which drug was received. Main treatment characteristics were recorded (as total electric charge 
received seizure threshold, number of treatments, and the mean time for recovery) along the whole treatment. Results: Thiopental and 
propofol were associated with a significance increase in charge needed to induce a seizure (p < 0.0001) when compared to etomidate, 
as well as a significant decrease of time for recovery (p = 0.042). Conclusions: These findings suggest that, although there seems to 
be no difference in the clinical outcome across these three drugs, propofol offers the best recovery profile. However, it makes a higher 
mean electric charge necessary.
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Resumo
Objetivos: Comparar o tempo de recuperação dos pacientes após eletroconvulsoterapia avaliada com a escala de recuperação pós-
anestésica de Aldrete e Kroulik, utilizando três tipos de medicações anestésicas (propofol, etomidato and tiopental). Método: Trinta 
pacientes foram randomizados para receber uma das medicações (n = 10 em cada grupo) durante uma série de tratamentos com 
eletroconvulsoterapia. Os pacientes e o examinador ficaram cegos para o tipo de anestésico utilizado. As principais características do 
tratamento foram avaliadas (como carga total de eletricidade recebida, limiar convulsivo, número de sessões e o tempo médio para 
recuperação) ao longo de toda a série de tratamentos. Resultados: Tiopental e propofol se associaram a um aumento significativo na 
carga elétrica total utilizada (p < 0,0001) quando comparados com etomidato, bem como uma diminuição significativa no tempo de 
recuperação pós-anestésica (p = 0,042). Conclusões: Estes achados sugerem que, apesar de não haver diferença na evolução clínica 
entre os três grupos estudados, a droga propofol oferece o melhor perfil de recuperação apesar de requerer uma carga elétrica média 
maior.
Descritores: Eletroconvulsoterapia; Anestesia; Sistemas de medicação; Diagnóstico medicamentoso; Recuperação psicomotora
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Introduction
Electroconvulsive therapy (ECT) is a widely used treatment 
for many mental disorders, especially depression.1 Since its first 
use in 1938 until nowadays, the technique has become safer 
and with fewer side effects. The introduction of anesthesia made 
risks of fractures and muscle pain absent and the treatment more 
comfortable, safer and easier to be accepted by patients.2
The most used medications for anesthesia induction in ECT 
include methohexital, thiopental, etomidate and propofol.2
Methohexital is the drug of choice for ECT anesthesia but it is 
not available in Brazil.3 Thiopental is a barbituric derivate, like 
methohexital, and its use is limited by a longer time of action and 
anticonvulsant effects.2 Propofol is a short acting non barbituric 
also widely used, with antihypertensive properties.4 Its main 
limitation is that it shortens seizure duration, possibly making ECT 
ineffective for some patients.5 Finally, etomidate is an imidazolic 
non barbituric derivate, with rapid onset, short time of action and 
fast metabolization. It has not analgesic properties and induces 
minimal cardio-respiratory effects. 6 Therefore, it is the drug of choice 
for patients with cardiac insufficiency.7 It also induces mioclonic 
movements with no clinical significance and has a minimal effect 
on seizure threshold. It is the drug mostly used in our Service.
There are few studies comparing the different drugs used for ECT 
anesthesia8-11 and most of them are focused on the effects on seizure 
duration12 and seizure threshold.
The aim of this randomized, double blind study was to compare 
post anesthetic recovery between three of the main drugs used in 
ECT (thiopental, propofol and etomidate).
Method
The study protocol and informed consent were approved by the 
local Research Ethics Committee, and all patients signed it before 
their enrollment in the trial.
The sample consisted of 30 patients who were scheduled to 
receive ECT, aged 18 to 60, with major depression according to 
DSM-IV and a minimum score of 22 as measured by the Hamilton 
Rating Scale for Depression (HRSD).13 They were randomly assigned 
to receive etomidate, propofol or thiopental during their course of 
ECT.
Patients and raters were blinded to which anesthetic drug was 
given.
In each ECT session, post anesthetic recovery was evaluated 
using the post anesthetic Recovery Score of Aldrete and Kroulik.14 
This scale monitors recovery through clinical observations, such as 
movement of extremities, respiration, systolic blood pressure, level 
of consciousness and skin coloration. The classic assessment is 
performed after arrival at recovery room and then after 1 hour, 2 
hours and 3 hours, although some hospitals include assessments 
every 15 minutes during the first hour. Scores vary from 0 to 10 
and scores of 8-9 are considered safe. As post ECT recovery takes 
a very short time compared with other procedures, mean time for 
recovery for each patient in each session was also recorded (patients 
were evaluated every 2-3 minutes; right after patients recovered 
spontaneous respiration, they went to the recovery room and time 
began to be counted.). Rater measured the total time (in minutes) to 
achieve a score of, at least, 8. Patients were evaluated in all sessions 
received, and the mean time for recovery was recorded.
ECT was performed according to international standards approved 
in our Institution. A SpECTrum 5000 Q® (MECTA Corporation, Lake 
Oswego, OR) was used. All patients used right unilateral electrode 
placement15 and seizure was monitored with EEG recording. Method 
of limits (titration) was used in the first session to determine seizure 
threshold (ST). In the following sessions, a charge of 6 times ST 
was used.
During each ECT session, patients received Oxygen 100%. For 
neuromuscular blockade, succinylcholine (0.5-1.25 mg/Kg IV) was 
used. All patients also received atropine (0.25-0.5 mg IV). The 
anesthetic dosages were: etomidate at 0.15-0.30 mg/Kg intravenous 
(IV), propofol at 1.0-1.5 mg/Kg IV, and thiopental at 2.0-3.0 mg/Kg IV. 
Each patient received the same anesthetic drug during the study, 
until the end of the ECT sessions.
All analyses were carried out using SAS v 9.0 (Cary, NC, USA). 
The aim of this study was to investigate the effects of the three 
different types of anesthetics. We initially studied the relationship 
of anesthetics with post anesthetic recovery and some other 
characteristics of the sample (as total charge received, seizure 
threshold, and total number of treatments received). Logistic 
regression models in which the dependent variable was the time 
for recovery and the independent variable was the anesthetic type 
were performed. We dichotomized the dependent variables using 
the median as a cutoff. A multinomial logistic regression model 
was performed in which propofol and thiopental were compared 
with etomidate. This model has an advantage as the Wald test can 
calculate the overall significance of a variable taking into account 
all the levels of the dependent variable and therefore increasing the 
power of this analysis.
Given we used categorical data, our sample size (10 patients in 
each group) is sufficient to detect differences in proportion with the 
magnitude of 0.3 using a power of 90% and alpha of 5%. In other 
words a change in 30% of recovery time would be detected using 
our sample size. We considered that a smaller change in recovery 
time would not be considered clinically significant. 
Results
Main characteristics of the groups can be seen in Table 1.
No statistical difference was found for mean number of 
sessions between the groups (7.9 ± 1.5 for propofol, 8.7 ± 
1 for etomidate, and 8.8 ± 0.4 for thiopental). The variables 
total electric charge received (p < 0.0001), and time for patient 
recovery (p = 0.042) were significantly associated with the type 
of anesthetic used. For instance, thiopental and propofol were 
associated with a significant increase in charge (OR = 5.33 and 
OR = 18.97, respectively) when compared to etomidate, as well 
as a significant decrease of time for recovery (OR = 0.49 and 
OR = 0.50, respectively). The multinomial logistic regression 
model confirmed these findings, as charge (p = 0.0002) and 
time for patient recovery (p = 0.014) remained significant 
after the adjustment for the other variables. Propofol needed 
the highest charge but had the shortest time for recovery. No 
difference was observed between groups related to seizure 
threshold and total number of treatments received.
Discussion
Post anesthetic recovery in ECT is a very important issue with 
practical implications for psychiatrists who work directly with ECT 
and for practitioners who prescribe it. The more comfortable the 
treatment, the better will be the patients’ compliance and satisfaction. 
Although any of the drugs used in this study showed a very short 
time for recovery, the best one was propofol. On the other hand, 
clinical superiority for practical purposes could not be proved, as 
time differences detected were around only 2 minutes between 
drug groups.
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An important point is that higher charges given are commonly 
associated with more frequent post ictal confusion. The significantly 
higher mean charge used with propofol (that could possibly make 
post ECT recovery worse) did not prevent it to show the best post 
anesthetic recovery profile. 
The main limitation of the study is that the scale used has different 
variables to measure recovery (such as color of skin, movement of 
the legs etc, more important for surgical procedures than for ECT). 
The most important one to patients undergoing ECT seems to be 
the level of consciousness (especially orientation), a variable that 
has a low sensitivity. Another limitation of our study is the relatively 
small sample size. Using this sample size, the number of variables 
that can be included in the multivariate model is limited. Indeed 
our model can only accept two or three variables at the same time. 
Therefore, larger sample sizes are necessary to build more complex 
models that include other variables and confounders.
Finally, clinical improvement or memory side effects were not 
compared in the current study and no conclusion can be drawn 
about the superiority of any of these drugs in clinical practice. In 
fact, the slight superiority found was not significant enough to make 
it the drug of choice, independently of other variables.
Studies comparing time for and quality of re-orientation and 
patients’ satisfaction for different drugs are highly encouraged.
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